Home » Reports » Broker Ratings » Hikma Pharmaceuticals Plc 14.2% Potential Upside Indicated by Jefferies International

Hikma Pharmaceuticals Plc 14.2% Potential Upside Indicated by Jefferies International

Hikma Pharmaceuticals Plc using EPIC/TICKER code (LON:HIK) has had its stock rating noted as ‘Upgrades’ with the recommendation being set at ‘BUY’ today by analysts at Jefferies International. Hikma Pharmaceuticals Plc are listed in the Health Care sector within UK Main Market. Jefferies International have set their target price at 2000 GBX on its stock. This now indicates the analyst believes there is a possible upside of 14.2% from today’s opening price of 1752 GBX. Over the last 30 and 90 trading days the company share price has decreased 25.5 points and decreased 198 points respectively. The 52 week high share price is 2089 GBX while the year low stock price is currently 814.2 GBX.

Hikma Pharmaceuticals Plc has a 50 day moving average of 1,848.79 GBX and a 200 Day Moving Average share price is recorded at 1,541.82. There are currently 241,445,043 shares in issue with the average daily volume traded being 725,731. Market capitalisation for LON:HIK is £4,116,078,130 GBP.